MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
A Prospective, Multicenter, Prospective, Non-intervention, Controlled Trial of MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer in Realistic Medical Practice
1 other identifier
observational
484
1 country
1
Brief Summary
This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 2, 2018
CompletedFirst Posted
Study publicly available on registry
January 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJanuary 17, 2018
January 1, 2018
2.2 years
January 2, 2018
January 9, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
overall survival
From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Secondary Outcomes (1)
Differences in overall survival after performing MDT at center
1 years
Study Arms (3)
fully implemented to the MDT decision
group of patients fully implemented to the MDT decision
not completly implemented to the MDT-decision
group of patients not completly implemented to the MDT decision
not implemented to the MDT decision
group of patients not implemented to the MDT decision
Interventions
due to suggestion of Multi-disciplinary Treatment ,the patients would be suggested to chemotherapy or surgery.
Eligibility Criteria
recurrent / metastatic gastric or colorectal cancer
You may qualify if:
- Histopathological diagnosis of recurrent / metastatic gastric or colorectal cancer.
- Participate in formal MDT discussions at the Research Center.
- MDT decision-making at least two subjects involved in treatment.
- Patient informed consent and signed written consent.
You may not qualify if:
- Early or locally advanced gastric cancer or colorectal cancer.
- Accept informal MDT discussions.
- MDT decisions recommend only a single subject for treatment of patients.
- MDT decisions recommend only palliative patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of department of Gastroentestinal oncology
Study Record Dates
First Submitted
January 2, 2018
First Posted
January 17, 2018
Study Start
November 1, 2017
Primary Completion
January 1, 2020
Study Completion
June 1, 2020
Last Updated
January 17, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share